Detailed price information for 4D Molecular Therapeutics Inc (FDMT-Q) from The Globe and Mail including charting and trades.
Detailed price information for 4D Molecular Therapeutics Inc (FDMT-Q) from The Globe and Mail including charting and trades.
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...
Zacks Investment Research on MSN
Strength seen in 4D Molecular Therapeutics (FDMT): Can its 7.9% jump turn into more strength?
4D Molecular Therapeutics, Inc. (FDMT) shares soared 7.9% in the last trading session to close at $10.42. The move was backed by solid volume with far more shares changing hands than in a normal ...
4D Molecular Therapeutics (NASDAQ:FDMT) stock is trading lower on Thursday after the company released interim follow-up data from the Phase 1/2 PRISM clinical trial and 4FRONT Phase 3 study design.
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in MSC Industrial Direct Co Inc (Symbol: MSM), where a total of 4,676 contracts have traded so ...
4D Molecular Therapeutics (NASDAQ:FDMT) shares are trading lower after the company released interim clinical data from the Phase 1 Dose Exploration stage of the 4D-150 Phase 1/2 PRISM trial for wet ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results